Arkansas Department of Health, Public Health Laboratory, Little Rock, AR, United States.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):234-43. doi: 10.1016/j.pnpbp.2012.04.017. Epub 2012 Apr 26.
"K2" and "Spice" drugs (collectively hereafter referred to as Spice) represent a relatively new class of designer drugs that have recently emerged as popular alternatives to marijuana, otherwise characterized as "legal highs". These drugs are readily available on the Internet and sold in many head shops and convenience stores under the disguise of innocuous products like herbal blends, incense, or air fresheners. Although package labels indicate "not for human consumption", the number of intoxicated people presenting to emergency departments is dramatically increasing. The lack of validated and standardized human testing procedures and an endless supply of potential drugs of abuse are primary reasons why researchers find it difficult to fully characterize clinical consequences associated with Spice. While the exact chemical composition and toxicology of Spice remains to be determined, there is mounting evidence identifying several synthetic cannabinoids as causative agents responsible for psychoactive and adverse physical effects. This review provides updates of the legal status of common synthetic cannabinoids detected in Spice and analytical procedures used to test Spice products and human specimens collected under a variety of clinical circumstances. The pharmacological and toxicological consequences of synthetic cannabinoid abuse are also reviewed to provide a future perspective on potential short- and long-term implications.
“K2”和“香料”(统称香料)代表了一类相对较新的设计师药物,最近作为大麻的流行替代品出现,通常被称为“合法兴奋剂”。这些药物在互联网上很容易买到,并在许多专卖店和便利店以草药混合物、香薰或空气清新剂等无害产品的形式出售。尽管包装标签上注明“不可食用”,但因摄入这些药物而到急诊室就诊的人数却在急剧增加。缺乏经过验证和标准化的人体测试程序以及源源不断的潜在滥用药物,是研究人员难以充分描述与香料相关的临床后果的主要原因。虽然香料的确切化学成分和毒理学仍有待确定,但越来越多的证据表明,几种合成大麻素是导致精神活性和不良身体影响的原因。本文综述了在 Spice 中检测到的常见合成大麻素的法律地位的最新情况,以及用于检测 Spice 产品和在各种临床情况下收集的人体标本的分析程序。还综述了合成大麻素滥用的药理学和毒理学后果,以期对潜在的短期和长期影响提供未来展望。
Prog Neuropsychopharmacol Biol Psychiatry. 2012-4-26
Adicciones. 2009
Psychopharmacology (Berl). 2013-7-9
Front Behav Neurosci. 2011-9-21
Curr Drug Abuse Rev. 2011-6
Int J Drug Policy. 2011-4-8
Tidsskr Nor Laegeforen. 2012-10-30
Brain Behav. 2025-4
Naunyn Schmiedebergs Arch Pharmacol. 2025-2
Harm Reduct J. 2024-7-1
Plants (Basel). 2024-1-15
Int J Ment Health Syst. 2023-10-25
Chem Res Toxicol. 2012-3-15
J Mass Spectrom. 2012-1
Prog Neuropsychopharmacol Biol Psychiatry. 2011-12-30
J Med Toxicol. 2012-3
Drug Alcohol Depend. 2011-11-27
Ann N Y Acad Sci. 2011-11-17